Source: MedicalMarketing& Media

ArsenalBio: Nate Hardy joined Arsenal Biosciences as CFO.

Nate Hardy joined Arsenal Biosciences as CFO.

Read full article »

ArsenalBio's Competitors | ArsenalBio's News | ArsenalBio's Financials

Followers on Owler

594

Est. Annual Revenue

$5.0-25M

Est. Employees

100-250

Chairman & CEO

Ken Drazan

CEO Approval Rating

88/100

ArsenalBio is a California-based clinical-stage cell therapy company that researches and develops solid tumor cell therapies for the treatment of cancer.